| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 211.24▼ | 211.69▼ | 212.37▼ | 223.11▼ | 225.02▼ |
| MA10 | 211.28▼ | 212.77▼ | 217.64▼ | 224.20▼ | 224.90▼ |
| MA20 | 211.35▼ | 218.93▼ | 223.24▼ | 227.07▼ | 218.85▼ |
| MA50 | 212.57▼ | 223.90▼ | 224.78▼ | 226.89▼ | 235.21▼ |
| MA100 | 216.73▼ | 225.14▼ | 226.76▼ | 219.57▼ | 256.43▼ |
| MA200 | 223.13▼ | 226.79▼ | 226.89▼ | 231.06▼ | 257.43▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.089▲ | -0.587▼ | -1.861▼ | -1.292▼ | 1.300▲ |
| RSI | 39.785▼ | 23.865▼ | 25.478▼ | 35.217▼ | 41.507▼ |
| STOCH | 40.203 | 17.000▼ | 11.094▼ | 27.286 | 56.652 |
| WILL %R | -69.652 | -94.421▼ | -95.795▼ | -95.821▼ | -59.293 |
| CCI | -139.590▼ | -87.986 | -77.663 | -285.202▼ | -51.320 |
| RSI | $BIIB RSI(14) Crossed Below 50 | Set Alert |
| MA | $BIIB Price Crossed Below MA(50) | Set Alert |
| MA | $BIIB Price Crossed Below MA(26) | Set Alert |
| MA | $BIIB Price Crossed Below MA(7) | Set Alert |
| ▼ GAP | $BIIB Open Gap Down %5 | Set Alert |
| ▼ GAP | $BIIB Open Gap Down %3 | Set Alert |
| ▼ GAP | $BIIB Open Gap Down %2 | Set Alert |
| ▼ BREAK | $BIIB Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $BIIB Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $BIIB Price Breaks 10 Days Low | Set Alert |
| CDL | $BIIB Doji Candlestick Pattern Detected | Set Alert |
|
Friday, July 26, 2024 08:31 AM
U.S. stock futures rose Friday, rebounding after hefty losses in megacap tech this week, as inflation data was in-line with consensus. Here are some of the biggest U.S. stock movers today: ...
|
|
Friday, July 26, 2024 08:18 AM
AbbVie (NYSE:ABBV) has discontinued a Phase 2 program for its Alzheimer’s therapy, ABBV-916, citing the candidate’s lack of differentiation from the currently approved drugs. “The emerging efficacy ...
|
|
Friday, July 26, 2024 07:21 AM
On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a negative opinion on the approval of Eisai Co., Ltd (OTC:ESALY) (OTC:ESALF) and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/07/24 | 211.38 | 217.53 | 210.00 | 211.17 | 2,255,900 |
| 25/07/24 | 227.20 | 236.48 | 226.04 | 227.44 | 1,138,600 |
| 24/07/24 | 224.10 | 228.07 | 223.11 | 226.03 | 908,400 |
| 23/07/24 | 226.29 | 228.05 | 223.53 | 224.29 | 839,431 |
| 22/07/24 | 227.73 | 228.48 | 223.62 | 226.63 | 692,400 |
| 19/07/24 | 225.67 | 227.63 | 222.38 | 226.40 | 851,800 |
| 18/07/24 | 224.85 | 231.27 | 224.145 | 225.14 | 827,504 |
| 17/07/24 | 223.39 | 230.10 | 221.67 | 228.33 | 949,500 |
| 16/07/24 | 221.79 | 228.57 | 220.81 | 225.02 | 1,006,200 |
| 15/07/24 | 230.06 | 230.06 | 221.21 | 221.58 | 1,329,691 |
|
|
||||
|
|
||||
|
|